Elanco Animal Health: Building On Success
Elanco Animal Health is making progress on debt repayment, new product approvals, and launches. Learn why ELAN stock is a Buy ...
pharmaphorum5y
Bayer boosts cell therapy pipeline with BlueRock acquisition
Bayer has announced it is fully acquiring US ... put these plans on hold to explore a merger of the unit with US firm Elanco.
Hosted on MSN5mon
6 Pet Stocks to Watch in 2024
A growth driver has been merger and acquisition activity. In August 2020, Elanco closed its $6.9 billion acquisition of Bayer Animal Health. In July 2024, it closed the sale of its Aqua business ...
Barclays Keeps Their Buy Rating on Elanco Animal Health (ELAN)
In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Elanco Animal Health (ELAN – Research Report), with a price ...
Positive Outlook for Elanco Animal Health Driven by Zenrelia and Growth Potential in EBITDA and EPS
Analyst Jonathan Block of Stifel Nicolaus maintained a Buy rating on Elanco Animal Health (ELAN – Research Report), reducing the price target ...
Hosted on MSN1mon
More than 200 agriculture lobbyists attend COP29 climate talks, analysis reveals
They come from organisations such as food giant PepsiCo, animal pharmaceuticals company Elanco and JBS, the world’s largest meat company. Nestle, the world’s largest food company and Bayer ...
weareaquaculture1d
INVE Aquaculture expands its team to focus on health solutions
New Product Manager Dr. Jan Koesling has over 20 years of experience in animal health, with a particular focus on aquatic animals in ponds and cages. Product Team – INVE Aquaculture: Eva Werbrouck ...